EFFECT OF PH ON MHC CLASS II-PEPTIDE INTERACTIONS

被引:0
|
作者
SETTE, A
SOUTHWOOD, S
OSULLIVAN, D
GAETA, FCA
SIDNEY, J
GREY, HM
机构
来源
JOURNAL OF IMMUNOLOGY | 1992年 / 148卷 / 03期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of pH on class II-peptide interactions has been analyzed using several mouse (IA(d), IA(k), IE(d), IE(k)) and human (DR1, DR5, DR7) MHC specificities, and eight different class II-restricted determinants. In direct binding assays, acidic conditions led to increased binding capacity for many class II-peptide combinations. IE molecules seemed to bind optimally around pH 4.5, whereas IA molecules displayed binding optima in the 5.5 to 6.5 range. In contrast, the DR molecules studied were, in most cases, affected only marginally by pH changes in the 4.5 to 7.0 range. Despite these apparent isotype-specific trends, no general rule could be formulated, because even for the same class II molecules, the binding capacity could be increased for many peptides when the binding was performed under acidic conditions, was unaffected for some, and even decreased for others. The mechanisms responsible for this complex behavior were analyzed in more detail by kinetic and equilibrium analysis of three different class II-peptide combinations (IA(d)/OVA 323339, IA(k)/HEL 46-61, and DR1/HA 307-319). It was found that acidic pH conditions could affect both on and off rates for class II-peptide complexes. Depending on the net balance of these effects, either increases, decreases, or no effect on overall affinities at equilibrium were detected. In the case of IA(d)/OVA 323-339, it was also found that acidic conditions influenced the binding capacity of class II molecules by increasing the fraction of sites available for peptide binding, presumably by favoring dissociation of endogenously bound, acid-sensitive peptides.
引用
收藏
页码:844 / 851
页数:8
相关论文
共 50 条
  • [1] Residue contribution in MHC class II-peptide interaction in autoimmunity
    Oashi, T
    Osman, R
    [J]. BIOPHYSICAL JOURNAL, 2003, 84 (02) : 465A - 465A
  • [2] Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras
    Casares, S
    Bona, CA
    Brumeanu, TD
    [J]. PROTEIN ENGINEERING, 2001, 14 (03): : 195 - 200
  • [3] Effect of pH on cooperativity in peptide binding to MHC class II
    Crane, Kyle
    Castellini, J. Margaret
    Hoffman, Megan
    Gotti, Marie
    Ferrante, Andrea
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192
  • [4] Energetic asymmetry among hydrogen bonds in MHC class II-peptide complexes
    McFarland, BJ
    Katz, JF
    Beeson, C
    Sant, AJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) : 9231 - 9236
  • [5] BiodMHC: an online server for the prediction of MHC class II-peptide binding affinity
    Wang, Lian
    Pan, Danling
    Hu, Xihao
    Mao, Jinyu
    Gao, Yangyang
    Zhang, Huifang
    Zhang, Yan
    Liu, Juan
    Zhu, Shanfeng
    [J]. JOURNAL OF GENETICS AND GENOMICS, 2009, 36 (05) : 289 - 296
  • [6] Association of MHC class II-peptide complexes with plasma membrane lipid microdomains
    Poloso, NJ
    Roche, PA
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) : 103 - 107
  • [7] DISTINCT KINETIC STATES OF MHC CLASS II-PEPTIDE INTERACTION CORRELATE WITH DISTINCT CLASS-II STRUCTURES
    SADEGHNASSERI, S
    STERN, L
    WILEY, D
    GERMAIN, R
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 73 - 73
  • [8] Generation of MHC class II-peptide ligands for CD4 T-cell allorecognition of MHC class II molecules
    Leddon, Scott A.
    Sant, Andrea J.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2010, 15 (04) : 505 - 511
  • [9] MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse
    Hiltbold, EM
    Poloso, NJ
    Roche, PA
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (03): : 1329 - 1338
  • [10] Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens
    Golovkina, TV
    Agafonova, Y
    Kazansky, D
    Chervonsky, A
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (04): : 2244 - 2250